Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_assertion type Assertion NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_head.
- NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_assertion description "[Persistent production of IFN-?, the most abundant subtype measured in these patients, is an important feature of the immunopathogenesis of lupus and has stimulated current efforts to develop and test therapeutics that either block IFN-I or its receptor directly or target components of the IFN-I pathway involved in induction of or response to IFN-I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_provenance.
- NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_assertion evidence source_evidence_literature NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_provenance.
- NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_assertion SIO_000772 25468480 NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_provenance.
- NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_assertion wasDerivedFrom befree-2016 NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_provenance.
- NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_assertion wasGeneratedBy ECO_0000203 NP1244278.RAeLqoC3q1OQrbECamh-OSpVkQ4_nXwIzA8Wyj2s4KFBg130_provenance.